Quantifying sclerotic bone metastases with 2D ultra short TE MRI: A feasibility study

Cancer Biomarkers

Volumn 7, Issue 4-5, 2010, Pages 211-218

  Messiou, C ^a   Collins, D J ^a   Morgan, V A ^a   Robson, M D ^b   Debono, J S ^a   Bydder, G M ^c   Desouza, N M ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bone; computed tomography; magnetic resonance imaging; metastasis

Indexed keywords

ADULT; AGED; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HUMAN; LUMBAR SPINE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CARCINOMA; SIGNAL NOISE RATIO; TREATMENT RESPONSE;

ADULT; AGED; BONE NEOPLASMS; FEASIBILITY STUDIES; HUMANS; LUMBAR VERTEBRAE; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; SCLEROSIS;

EID: 79955612885     PISSN: 15740153     EISSN: None     Source Type: Journal    
DOI: 10.3233/CBM-2010-0189     Document Type: Article

References (12)

1. B.I. Carlin, G.L. Andriole et al., The natural history,skeletal complications and management of bone metastases in patients with prostate carcinoma, Cancer 88 (2000), 2989-2994. (Pubitemid 30413181)
2. CM Costelloe, E.M. Rohren, J.E. Madewell, T. Hamaoka, R.L. Theriault, T.K. Yu et al., Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis, Lancet Oncol 10(6) (2009 Jun), 606-614.
3. T.K. Pollen, K.F. Witztum and W.L. Ashburn, The flare phe-nomenon on radionuclide bone scan in metastatic prostate cancer, AJR 142 (1984), 773-776. (Pubitemid 14166610)
4. E.A. Eisenhauer, P. Therasse, J. Bogaerts, L.H. Schwartz, D. Sargent, R. Ford et al., New response evaluation criteria in solidtumours: revised RECIST guideline (version 1.1),EurJ Cancer 45(2) (2009 Jan), 228-247.
5. M.D. Robson, PD. Gatehouse, M. Bydder and G.M. Bydder, Magnetic resonance: an introduction to ultrashort TE (UTE) imaging, JComputAssist Tomogr 27(6) (2003 Nov), 825-846. (Pubitemid 37420776)
6. P.D. Gatehouse and G.M. Bydder, Magnetic resonance imag-ing of short T2 components intissue, ClinRadiol 58(1) (2003 Jan), 1-19. (Pubitemid 36104938)
7. M.D. Robson and G.M. Bydder, Clinical ultrashort echo time imaging of bone and other connective tissues, NMR Biomed 19(7) (2006 Nov), 765-780. (Pubitemid 44811542)
8. G.J. Bubley etal.,Eligibility andresponseguidelines forphase II clinical trials in androgen-independent prostate cancer: rec-ommendations from the Prostate-Specific Antigen Working Group, JClinOncol 17(11) (1999), 3461-3467. (Pubitemid 29517916)
9. M.J. Firbank, A. Coulthard, R.M. Harrison andE.D. Williams, A comparison of two methods for measuring the signal to noise ratio on MR Images, Physics Medicine and Biology 44 (1999), 261-264.
10. T Knöös, M. NilssonandL. Ahlgren, A method for conversion of Hounsfield number to electron density and prediction of macroscopic pair production cross-sections, RadiotherOncol 5(4) (1986 Apr), 337-345. (Pubitemid 16034499)
11. J.J. Pollen and R.H. Reznek, TalnerLB.Lysis of osteoblastic lesions in prostatic cancer: a sign of progression, AJR Am J Roentgenol 142(6) (1984 Jun), 1175-1179. (Pubitemid 14112870)
12. TR. Fleming and D.L. DeMets, Surrogate end points in clini-cal trials: are we being misled, Ann InternMed 125(7) (1996 Oct 1), 605-613. (Pubitemid 126450094)